We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KG
12551
Kestrel Group
KG
$61.7M
$126K ﹤0.01%
1,866
-4,974
-73% -$346K
PRPH
12552
CALL
DELISTED
ProPhase Labs
PRPH
$126K ﹤0.01%
2,030
+900
+80% +$50.5K
SCM icon
12553
Stellus Capital Investment Corp
SCM
$250M
$126K ﹤0.01%
10,005
-631
-6% -$8.32K
XAIR icon
12554
CALL
Beyond Air
XAIR
$5.6M
$126K ﹤0.01%
49
-85
-63% -$186K
GENE
12555
PUT
DELISTED
Genetic Technologies Ltd.
GENE
$126K ﹤0.01%
5,920
-2,640
-31% -$53.2K
NBSE
12556
CALL
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$126K ﹤0.01%
1,310
+805
+159% +$88.9K
ADV icon
12557
PUT
Advantage Solutions
ADV
$420M
$125K ﹤0.01%
+464
New +$143K
BCDA icon
12558
BioCardia
BCDA
$14.7M
$125K ﹤0.01%
2,092
+656
+46% +$39.8K
CRMD icon
12559
PUT
CorMedix
CRMD
$588M
$125K ﹤0.01%
18,200
-2,100
-10% -$16.7K
HROW icon
12560
PUT
Harrow
HROW
$1.5B
$125K ﹤0.01%
13,500
-78,200
-85% -$667K
KRMD icon
12561
KORU Medical Systems
KRMD
$157M
$125K ﹤0.01%
26,947
+9,502
+54% +$37.3K
TRT
12562
Trio-Tech International
TRT
$116M
$125K ﹤0.01%
49,522
+20,762
+72% +$52.6K
BEST
12563
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$125K ﹤0.01%
3,520
+2,605
+285% +$74.7K
SEEL
12564
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$125K ﹤0.01%
12
-20
-63% -$329K
HUGS.U
12565
DELISTED
USHG Acquisition Corp. Units, each consisting of one share of Class A Common Stock, and one-third of one Warrant
HUGS.U
$125K ﹤0.01%
12,475
-692,413
-98% -$6.99M
TMAC
12566
DELISTED
The Music Acquisition Corporation
TMAC
$125K ﹤0.01%
12,943
-1,712
-12% -$16.7K
DRV icon
12567
CALL
Direxion Daily Real Estate Bear 3X ETF
DRV
$25.3M
$124K ﹤0.01%
2,340
-3,410
-59% -$206K
KOS icon
12568
CALL
Kosmos Energy
KOS
$1.51B
$124K ﹤0.01%
+35,900
New +$111K
RUMBW
12569
RUM Group Inc Warrant
RUMBW
$13.4M
$124K ﹤0.01%
+125,000
New +$112K
SAN icon
12570
CALL
Banco Santander
SAN
$210B
$124K ﹤0.01%
31,800
-48,400
-60% -$188K
SIGA icon
12571
PUT
SIGA Technologies
SIGA
$216M
$124K ﹤0.01%
19,800
+800
+4% +$5.5K
SLGL icon
12572
PUT
Sol-Gel Technologies
SLGL
$277M
$124K ﹤0.01%
+1,000
New +$116K
CBAY
12573
CALL
DELISTED
Cymabay Therapeutics
CBAY
$124K ﹤0.01%
28,400
+300
+1% +$1.33K
LFTR
12574
CALL
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$124K ﹤0.01%
+12,700
New +$125K
SRGA
12575
PUT
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$124K ﹤0.01%
2,983
-194
-6% -$9.94K
501 502
503
504 505

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.